Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5

Glycoconjugate vaccines based on isolated capsular polysaccharide (CPS) save millions of lives annually by preventing invasive pneumococcal disease caused by Streptococcus pneumoniae. Some components of the S. pneumoniae glycoconjugate vaccine Prevnar13 that contains CPS antigens from 13 serotypes u...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Proc Natl Acad Sci U S A
Hlavní autoři: Lisboa, Marilda P., Khan, Naeem, Martin, Christopher, Xu, Fei-Fei, Reppe, Katrin, Geissner, Andreas, Govindan, Subramanian, Witzenrath, Martin, Pereira, Claney L., Seeberger, Peter H.
Médium: Artigo
Jazyk:Inglês
Vydáno: National Academy of Sciences 2017
Témata:
Physical Sciences
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651752/
https://ncbi.nlm.nih.gov/pubmed/28973947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1706875114
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky